Parents of Toddler with Childhood Dementia Plead for Government Research Funding
The parents of a two-year-old girl diagnosed with a rare neurodegenerative condition known as childhood dementia are making an urgent appeal to the government for increased research funding and support. Gus and Emily Forrester received the devastating diagnosis five months ago that their daughter Leni has Sanfilippo disease, a terminal genetic disorder with no current cure or UK-approved treatment.
Every Parent's Worst Nightmare
Emily Forrester described the situation as "every parent's worst nightmare" in an exclusive interview with ITV News. "All your dreams for your child's future are taken away," she explained. "To be told that she has this condition, and there is no treatment and no cure and no support… it’s completely earth-shattering." Leni, described by her parents as "a bundle of joy" who loves making others laugh, appears like any healthy toddler but faces a grim prognosis.
The Race Against Time
Sanfilippo disease creates a deficiency of an enzyme that normally breaks down harmful molecules in the body. Without this crucial process, toxic chemicals accumulate, causing progressive and irreversible damage to the brain. Although children typically develop normally initially, around age three they begin losing physical and cognitive abilities, eventually requiring round-the-clock care. Life expectancy ranges from the teenage years to early twenties.
"Every day that passes without treatment, this toxic waste is building up in our child’s body," Emily emphasized. "If we can’t get treatment, she will suffer the most awful physical and mental decline you can imagine and then die in her early to mid-teens."
Clinical Trial Hopes and Government Inaction
A clinical trial for a new treatment is scheduled to begin in the United States later this year. Leni's parents are urging the UK government to help fund the study so British children can participate. Professor Brian Badger of the University of Edinburgh has developed a gene therapy that could help young Sanfilippo patients by introducing a missing gene into blood stem cells. However, beginning clinical trials requires significant funding that charities typically cannot provide.
"We’re racing against time," Professor Badger told ITV News. "She will start to lose brain cells and when that happens we’re not going to get them back. Charities typically can’t fund this kind of thing. It would be really good if we could see more commitment from government towards these kinds of therapies."
Broader Implications and Newborn Screening
The Forresters are also advocating for wider newborn screening to detect rare genetic conditions like Sanfilippo. Dad Gus noted, "When you group all these rare conditions together, they suddenly don’t become that rare. They affect a lot of people and a lot of families." He added, "As parents, your role is to protect your children and provide every opportunity you can. Without any treatment, her future and her reality is very, very dark."
Emily expressed frustration that families must fight for their children's lives. "We shouldn’t have to fight for our child’s life. She is as valuable as any other child. But no one is fighting for her." The timing of intervention is critical. "Early treatment is key for these children. The damage cannot be reversed once it’s done," she explained. "If she has to wait six months, that could mean she can no longer talk. If she waits 12 months, that could mean she loses the ability to walk."
Government Response and Ongoing Challenges
A Department of Health and Social Care spokesperson stated, "Our thoughts are with all those living with dementia and rare conditions including Sanfilippo syndrome. We are making sure patients with rare diseases, like Sanfilippo syndrome, get a definite diagnosis faster, while improving access to specialist care, treatment and drugs. At the same time we are working hard to find new ways to slow down the progress of the dementia, speed up diagnosis and improve our understanding of the disease."
Despite these assurances, the Forresters and medical experts stress that without immediate government investment in research and clinical trials, children like Leni face certain deterioration. Professor Badger concluded, "All of us have a family member who’s been affected by dementia. Childhood dementia is no different. It’s just much, much worse - because it’s your kid." The family's emotional battle highlights the urgent need for policy changes and funding allocations to address rare childhood diseases that collectively affect thousands of families across the United Kingdom.
